Journal
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
Volume 171, Issue 4, Pages 954-962Publisher
HUMANA PRESS INC
DOI: 10.1007/s12010-013-0415-8
Keywords
3-O-Sulfotransferase; Bioengineered heparin; Endotoxin free; Bacillus subtilis; Bacillus megaterium; Nonanimal sources
Funding
- National Institutes of Health [HL101721, HL096972]
- Bioengineered Heparin Consortium
- 863 Hi-Tech Research and Development Program of the People's Republic of China [2012AA022300]
Ask authors/readers for more resources
A key enzyme for the biosynthesis and bioengineering of heparin, 3-O-sulfotransferase-1 (3-OST-1), was expressed and purified in Gram-positive Bacillus subtilis and Bacillus megaterium. Western blotting, protein sequence analysis, and enzyme activity measurement confirmed the expression. The enzymatic activity of 3-OST-1 expressed in Bacillus species were found to be similar to those found when expressed in Escherichia coli. The endotoxin level in 3-OST-1 from B. subtilis and B. megaterium were 10(4)-10(5)-fold lower than that of the E. coli-expressed 3-OST-1, which makes the Bacillus expression system of particular interest for the generation of pharmaceutical grade raw heparin from nonanimal sources.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available